tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mitchell Kapoor, 208 are a BUY (87.76%), 21 are a HOLD (8.86%), 8 are a SELL (3.38%).
Analyst Mitchell Kapoor, carries an average stock price target met ratio of 35.85% that have a potential upside of 31.99% achieved within 63 days. Previously, Mitchell Kapoor worked at HC WAINWRIGHT.
Mitchell Kapoor’s has documented 467 price targets and ratings displayed on 26 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRSP, Crispr Therapeutics AG at 22-Sep-2025.
Analyst best performing recommendations are on SMMT (SUMMIT THERAPEUTICS PLC).
The best stock recommendation documented was for SMMT (SUMMIT THERAPEUTICS PLC) at 9/9/2024. The price target of $30 was fulfilled within 4 days with a profit of $10.86 (56.74%) receiving and performance score of 141.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$36
$-0.01 (-0.03%)
2 years 10 months 14 days ago
(22-Nov-2022)
1/1 (100%)
$0.4 (1.12%)
48
Hold
$36
$-0.01 (-0.03%)
$30
2 years 10 months 14 days ago
(22-Nov-2022)
2/2 (100%)
$0.4 (1.12%)
258
Hold
$36
$-0.01 (-0.03%)
$25
2 years 10 months 15 days ago
(21-Nov-2022)
2/2 (100%)
$0.41 (1.15%)
37
Buy
$36
3 years 1 months 19 days ago
(16-Aug-2022)
1/2 (50%)
$14.65 (68.62%)
290
Buy
$36
$-0.01 (-0.03%)
$31
3 years 6 months 10 days ago
(25-Mar-2022)
2/2 (100%)
$14.65 (68.62%)
379
Which stock is Mitchell Kapoor is most bullish on?
Which stock is Mitchell Kapoor is most reserved on?
What Year was the first public recommendation made by Mitchell Kapoor?
